Which of the following is the new drug for the treatment of multi drug resistant tuberculosis
Refer Harrison 19th/p1115 Bedaquline is a new drug approved for MDT tuberculosis. It acts by inhibiting ATP synthatase in mycobacterium . Major adverse effects of this drug is "QT prolongation
Bedaquline
Linezolide
Levofloxacin
Cefepime
Chemotherapy